Executives from the sequencing tech firms provided attendees with an update on recently launched products and platforms, and future technology developments.
Executives from 23andMe, Myriad Genetics, Genomic Health, and Alere provided updates on their companies at the JP Morgan Healthcare Conference in San Francisco.
The company also announced the Infinium XT genotyping array for analyzing large sample numbers, and provided preliminary earnings for Q4 and full-year 2015.
Officials from Luminex and BioNano Genomics provided strategic updates at the conference.
Sequenom CEO Bill Welch said at the JP Morgan Healthcare Conference that the company plans to bring "at least" three new laboratory-developed tests to market in 2015.
BGI's spinoff companies, BGI Tech and BGI Dx, have merged and will go public next year.
Officials from Exact Sciences, Cepheid, Bio-Rad, Biocartis, and NanoString provided strategic updates at the conference.
To date, Foundation Medicine has reported approximately 35,000 tests, of which 82 percent have a clinically relevant finding.
Officials from Thermo Fisher Scientific, Affymetrix, Danaher, Hologic, Genmark, and Accelerate Diagnostics provided strategic updates at the conference.
Officials from Genomic Health and Myriad Genetics updated investors and other attendees at the conference.
CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.
Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.
Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.
In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.